Interferon alpha 2 maintenance therapy may enable high rates of treatment discontinuation in chronic myeloid leukemia

Andreas Burchert(Philipps University of Marburg), Susanne Saußele(Heidelberg University), Ekkehard Eigendorff(Jena University Hospital), Martin C. Müller(Heidelberg University), Kristina Sohlbach(Philipps University of Marburg), Sabrina Inselmann(Philipps University of Marburg), Christin Schütz(Philipps University of Marburg), Stephan Metzelder(Philipps University of Marburg), Janine M. Ziermann(Jena University Hospital), Philippe Kostrewa(Philipps University of Marburg), Joerg Hoffmann(Philipps University of Marburg), Rüdiger Hehlmann(Heidelberg University), Andreas Neubauer(Philipps University of Marburg), Andreas Hochhaus(Jena University Hospital)
Leukemia
February 25, 2015
Cited by 61Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis